Skip Navigation


Carcinogenesis Advance Access originally published online on December 3, 2004
Carcinogenesis 2005 26(3):587-595; doi:10.1093/carcin/bgh346
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
26/3/587    most recent
bgh346v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Javid, S. H.
Right arrow Articles by Bertagnolli, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Javid, S. H.
Right arrow Articles by Bertagnolli, M. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis vol.26 no.3 © Oxford University Press 2004; all rights reserved.

ARTICLE

Modulation of tumor formation and intestinal cell migration by estrogens in the ApcMin/+ mouse model of colorectal cancer

Sara H. Javid, Amy E. Moran, Adelaide M. Carothers, Mark Redston1 and Monica M. Bertagnolli2

Department of Surgery and 1 Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA

2 To whom correspondence should be addressed. Tel: +1 617 732 8910; Fax: +1 617 582 6177; Email: mbertagnolli{at}partners.org

Epidemiological studies suggest that post-menopausal hormone replacement therapy (HRT) reduces colorectal cancer (CRC) incidence. Phytoestrogens, including the soy isoflavone genistein and coumestrol, are used by many women as alternatives to HRT. Previous studies showed that ovariectomy induced a 77% increase in intestinal adenoma number in the C57BL/6J-Min/+ (Min/+) mouse, an animal model of adenomatous polyposis coli (APC)-associated CRC. Replacement of estradiol (E2) in ovariectomized Min/+ mice reduced tumor number to baseline and up-regulated the expression of estrogen receptor ß (ERß). We hypothesized that the phytoestrogens genistein and coumestrol would inhibit intestinal tumorigenesis in ovariectomized Min/+ mice. Min/+ and Apc+/+ (WT) mice were ovariectomized and assigned to either a control diet or treatment with E2, genistein or coumestrol. Treatment of ovariectomized Min/+ (Min/+ OX) mice with genistein resulted in a non-significant reduction in tumor number. Min/+ OX mice treated with coumestrol had significantly fewer tumors than untreated Min/+ OX controls and the same number of tumors as non-ovariectomized Min/+ mice. Bromodeoxyuridine migration assays also demonstrated that treatment with E2 or coumestrol improved enterocyte migration rate. Immunoprecipitation and immunohistochemistry analyses showed that impaired association of the adherens junction proteins E-cadherin and ß-catenin in Min/+ mice was improved by treatment with either E2 or coumestrol. Immunoblot analyses also showed that expression of ERß was elevated in enterocytes of Min/+ OX mice treated with E2 or coumestrol as compared with those of untreated Min/+ OX mice. In conclusion, both coumestrol and E2 prevent intestinal tumorigenesis and ameliorate enterocyte migration and intercellular adhesion in the ApcMin/+ mouse model of CRC.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
J. D. Lambert, S.-J. Kwon, J. Ju, M. Bose, M.-J. Lee, J. Hong, X. Hao, and C. S. Yang
Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (-)-epigallocatechin-3-gallate
Carcinogenesis, October 1, 2008; 29(10): 2019 - 2024.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. B. Halberg, M. C. Larsen, T. L. Elmergreen, A. Y. Ko, A. A. Irving, L. Clipson, and C. R. Jefcoate
Cyp1b1 Exerts Opposing Effects on Intestinal Tumorigenesis via Exogenous and Endogenous Substrates
Cancer Res., September 15, 2008; 68(18): 7394 - 7402.
[Abstract] [Full Text] [PDF]

Home page
 GENES CELLSHome page
A. P. Kouzmenko, K.-i. Takeyama, Y. Kawasaki, T. Akiyama, and S. Kato
Ligand-dependent interaction between estrogen receptor alpha and adenomatous polyposis coli.
Genes Cells, July 1, 2008; 13(7): 723 - 730.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. J. Gunter, D. R. Hoover, H. Yu, S. Wassertheil-Smoller, T. E. Rohan, J. E. Manson, B. V. Howard, J. Wylie-Rosett, G. L. Anderson, G. Y.F. Ho, et al.
Insulin, Insulin-like Growth Factor-I, Endogenous Estradiol, and Risk of Colorectal Cancer in Postmenopausal Women
Cancer Res., January 1, 2008; 68(1): 329 - 337.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
A. A. Baran, K. A. Silverman, J. Zeskand, R. Koratkar, A. Palmer, K. McCullen, W. J. Curran Jr, T. B. Edmonston, L. D. Siracusa, and A. M. Buchberg
The modifier of Min 2 (Mom2) locus: Embryonic lethality of a mutation in the Atp5a1 gene suggests a novel mechanism of polyp suppression
Genome Res., May 1, 2007; 17(5): 566 - 576.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. L. Cho, S. H. Javid, A. M. Carothers, M. Redston, and M. M. Bertagnolli
Estrogen Receptors {alpha} and {beta} Are Inhibitory Modifiers of Apc-Dependent Tumorigenesis in the Proximal Colon of Min/+ Mice
Cancer Res., March 1, 2007; 67(5): 2366 - 2372.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. L. Slattery, C. Sweeney, M. Murtaugh, K. N. Ma, R. K. Wolff, J. D. Potter, B. J. Caan, and W. Samowitz
Associations between ER{alpha}, ER{beta}, and AR Genotypes and Colon and Rectal Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2936 - 2942.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.